The Impact of Placental Factors on Fetal Intrauterine Growth and in Intrauterine Programming of the Metabolic Syndrome
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01883154 |
Recruitment Status : Unknown
Verified June 2013 by Meir Medical Center.
Recruitment status was: Not yet recruiting
First Posted : June 21, 2013
Last Update Posted : June 21, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Normal Pregnancies |
Study Type : | Observational |
Estimated Enrollment : | 160 participants |
Official Title: | The Impact of Placental Factors on Fetal Intrauterine Growth and in Intrauterine Programming of the Metabolic Syndrome |
Study Start Date : | September 2013 |
Estimated Primary Completion Date : | September 2017 |
Estimated Study Completion Date : | September 2023 |
Group/Cohort |
---|
IUGR pregnancies
Pregnancies complicated with IUGR. Fetal growth beneath the 10th percentile
|
pregnancies with Gestational Diabetes
Normal glucose levels before 20 weeks, and positive Oral glucose tolerance test
|
Pre Gestational Diabetes
A diagnosis of Diabetes before pregnancy or elevated glucose levels before 20 weeks.
|
IVF pregnancies |
- Rate of Copy Number Variations [ Time Frame: 10 yeras ]
- Telomere length [ Time Frame: 10 years ]
- Number of copies of mitochondrial DNA [ Time Frame: 10 years ]
Biospecimen Retention: Samples With DNA
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- A diagnosis of Intrauterine growth restriction
- A diagnosis of Gestational diabetes
- A diagnosis of pre gestational Diabetes
- IVF pregnancy
Exclusion Criteria:
- chorioamnionitis
- meconium stained amniotic fluid
- A request of the patient for Cord blood retrieval for preservation
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01883154
Contact: Tal Biron Shental, MD | 972-52-836-2331 | Tal.Biron-Shental@clalit.org.il | |
Contact: Rivka Sukenik-Halevy, MD | 972-52-6007249 | riki.sukenik@gmail.com |
Israel | |
Meir medical center | |
Kfar Saba, Israel | |
Contact: Tal Biron Shental, MD | |
Sub-Investigator: Rivka Sukenik Halevy, MD | |
Principal Investigator: Tal Biron Shental, MD |
Responsible Party: | Meir Medical Center |
ClinicalTrials.gov Identifier: | NCT01883154 |
Other Study ID Numbers: |
loe135673ctil |
First Posted: | June 21, 2013 Key Record Dates |
Last Update Posted: | June 21, 2013 |
Last Verified: | June 2013 |
Metabolic Syndrome Insulin Resistance Hyperinsulinism Glucose Metabolism Disorders Metabolic Diseases |